Cargando…

Trimethylamine N-Oxide Levels in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Non-alcoholic fatty liver disease (NAFLD) represents an entity with an increasing prevalence which is characterized by significant hepatic and extrahepatic complications. Its pathophysiology is multifactorial, with gut dysbiosis being considered a major determinant. In this systematic review and met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Theofilis, Panagiotis, Vordoni, Aikaterini, Kalaitzidis, Rigas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784457/ https://www.ncbi.nlm.nih.gov/pubmed/36557281 http://dx.doi.org/10.3390/metabo12121243

Ejemplares similares

Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Metabolic Dysfunction-Associated Fatty Liver Disease in the National Health and Nutrition Examination Survey 2017–2020: Epidemiology, Clinical Correlates, and the Role of Diagnostic Scores
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Overview of infections as an etiologic factor and complication in patients with vasculitides
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Chronic Pain and Its Association with Depressive Symptoms and Renal Function in Hypertensive Patients
por: Kalaitzidis, Rigas G., et al.
Publicado: (2022)

Hypertension is the crucial link between obstructive sleep apnea and arterial stiffness
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Tadalafil in patients on antihypertensive medications: Does safety remain an issue?
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
por: Chen, Yu-ming, et al.
Publicado: (2016)

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2021)

Atherogenic Index of Plasma in Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2022)

Metformin decreases bacterial trimethylamine production and trimethylamine N-oxide levels in db/db mice
por: Kuka, Janis, et al.
Publicado: (2020)

The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Biciusca, Teodora, et al.
Publicado: (2023)

The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: A systematic review and meta-analysis of RCTs
por: Yu, Le, et al.
Publicado: (2017)

Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease
por: Navarro, Pilar, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression
por: Manzano-Nunez, Ramiro, et al.
Publicado: (2023)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
por: Dowman, J K, et al.
Publicado: (2011)

Circulating trimethylamine‐N‐oxide is associated with all‐cause mortality in subjects with nonalcoholic fatty liver disease
por: Flores‐Guerrero, Jose L., et al.
Publicado: (2021)

Higher Trimethylamine-N-Oxide Plasma Levels with Increasing Age Are Mediated by Diet and Trimethylamine-Forming Bacteria
por: Rath, Silke, et al.
Publicado: (2021)

Clinical guidelines of non-alcoholic fatty liver disease: A systematic review
por: Zhu, Jin-Zhou, et al.
Publicado: (2016)

Serum levels of Trimethylamine-N-oxide in patients with ischemic stroke
por: Rexidamu, Maimaiti, et al.
Publicado: (2019)

Association of Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease with COVID-19-Related Intensive Care Unit Outcomes: A Systematic Review and Meta-Analysis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review
por: Tovo, Cristiane V, et al.
Publicado: (2017)

Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review
por: Tidwell, Jasmine, et al.
Publicado: (2023)

Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies
por: Ebadi, Maryam, et al.
Publicado: (2021)

Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Mak, Anne Linde, et al.
Publicado: (2021)

Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Cianci, Nicole, et al.
Publicado: (2022)

Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy
por: Liu, Weiming, et al.
Publicado: (2020)

Association of Urinary and Plasma Levels of Trimethylamine N-Oxide (TMAO) with Foods
por: Lombardo, Mauro, et al.
Publicado: (2021)

Electronic fluctuation difference between trimethylamine N-oxide and tert-butyl alcohol in water
por: Kuroki, Nahoko, et al.
Publicado: (2022)

Trimethylamine N-Oxide (TMAO) and Indoxyl Sulfate Concentrations in Patients with Alcohol Use Disorder
por: Coulbault, Laurent, et al.
Publicado: (2022)

De novo non-alcoholic fatty liver disease after pancreatectomy: A systematic review
por: Shah, Parth, et al.
Publicado: (2022)

Trimethylamine N-Oxide: The Good, the Bad and the Unknown
por: Velasquez, Manuel T., et al.
Publicado: (2016)

Trimethylamine N-oxide in atrial fibrillation progression
por: Büttner, Petra, et al.
Publicado: (2020)

Trimethylamine N-oxide (TMAO) in human health
por: Gatarek, Paulina, et al.
Publicado: (2021)

Influence of Trimethylamine N-Oxide on Platelet Activation
por: Emonds, Julian Josef, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis
por: Goliopoulou, Athina, et al.
Publicado: (2023)

Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis
por: He, Kaiyin, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease: Implementing Complete Automated Diagnosis and Staging. A Systematic Review
por: Popa, Stefan L., et al.
Publicado: (2021)

The Evidence Surrounding Non-Alcoholic Fatty Liver Disease in Individuals with Cancer: A Systematic Literature Review
por: George, Elena S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rl719sdfo9ice5eq1p29i6h86e